Entity Wide Revenue Major Customer Number

No definition available.

Name:	anci_EntityWideRevenueMajorCustomerNumber
Namespace Prefix:	anci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue, Gross

+ References

No definition available.

+ Details

Name:	anci_RevenueGross
Namespace Prefix:	anci_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amounts due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 3

-Subparagraph a, b

-Article 5

+ Details

Name:	us-gaap_AccountsReceivableGrossCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name:	us-gaap_AccountsReceivableNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AllowanceForDoubtfulAccountsReceivable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate selling price reductions recognized during an accounting period due to the rendering of deficient or nonconforming services. Allowances are a deduction from gross revenue in arriving at net revenue.

+ References

+ Details

Name:	us-gaap_SalesAllowancesServices
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Revenue Recognition (Revenue and Accounts Receivable) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Concentration Risk [Line Items]
Entity Wide Revenue Major Customer Number			3
Accounts receivable, net	$ 2,309		$ 2,309		$ 1,977
Net revenues	5,971	6,443	10,979	14,048
Ancillary Network
Concentration Risk [Line Items]
Allowance for Uncollectable Receivables	(341)	(261)	(341)	(261)
Accounts receivable, net	2,046	2,615	2,046	2,615
Provision for refunds	(53)	(66)	(106)	(107)
Net revenues	5,497	6,443	10,505	14,048
Ancillary Network \| Sales Revenue
Concentration Risk [Line Items]
% of Total Revenue	100.00%	100.00%	100.00%	100.00%
Ancillary Network \| Sales Revenue \| Provision for refunds
Concentration Risk [Line Items]
% of Total Revenue	(1.00%)	(1.00%)	(1.00%)	(1.00%)
Ancillary Network \| Customer Concentration Risk \| Material Client Relationship
Concentration Risk [Line Items]
Accounts Receivable, Gross	1,029	443	1,029	443
Revenue, Gross	2,312	1,438	3,544	3,795
Ancillary Network \| Customer Concentration Risk \| HealthSCOPE Benefits, Inc.
Concentration Risk [Line Items]
Accounts Receivable, Gross	91	160	91	160
Revenue, Gross	365	537	1,059	1,120
Ancillary Network \| Customer Concentration Risk \| HealthMarkets, Inc
Concentration Risk [Line Items]
Accounts Receivable, Gross	163	179	163	179
Revenue, Gross	363	881	862	1,537
Ancillary Network \| Customer Concentration Risk \| All Others
Concentration Risk [Line Items]
Accounts Receivable, Gross	1,104	2,094	1,104	2,094
Revenue, Gross	$ 2,510	$ 3,653	$ 5,146	$ 7,703
Ancillary Network \| Customer Concentration Risk \| Sales Revenue \| Material Client Relationship
Concentration Risk [Line Items]
% of Total Revenue	42.00%	22.00%	34.00%	27.00%
Ancillary Network \| Customer Concentration Risk \| Sales Revenue \| HealthSCOPE Benefits, Inc.
Concentration Risk [Line Items]
% of Total Revenue	7.00%	8.00%	10.00%	8.00%
Ancillary Network \| Customer Concentration Risk \| Sales Revenue \| HealthMarkets, Inc
Concentration Risk [Line Items]
% of Total Revenue	7.00%	14.00%	8.00%	11.00%
Ancillary Network \| Customer Concentration Risk \| Sales Revenue \| All Others
Concentration Risk [Line Items]
% of Total Revenue	45.00%	57.00%	49.00%	55.00%